HCW Biologics (HCWB) Competitors $0.45 +0.04 (+8.72%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCWB vs. IMRX, IMMX, ALTS, ALVR, STTK, IOBT, ITRM, CELU, PRLD, and VTVTShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include Immuneering (IMRX), Immix Biopharma (IMMX), Janone (ALTS), AlloVir (ALVR), Shattuck Labs (STTK), IO Biotech (IOBT), Iterum Therapeutics (ITRM), Celularity (CELU), Prelude Therapeutics (PRLD), and vTv Therapeutics (VTVT). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. Immuneering Immix Biopharma Janone AlloVir Shattuck Labs IO Biotech Iterum Therapeutics Celularity Prelude Therapeutics vTv Therapeutics HCW Biologics (NASDAQ:HCWB) and Immuneering (NASDAQ:IMRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment, community ranking and earnings. Does the media favor HCWB or IMRX? In the previous week, Immuneering had 5 more articles in the media than HCW Biologics. MarketBeat recorded 5 mentions for Immuneering and 0 mentions for HCW Biologics. Immuneering's average media sentiment score of 0.12 beat HCW Biologics' score of 0.00 indicating that Immuneering is being referred to more favorably in the news media. Company Overall Sentiment HCW Biologics Neutral Immuneering Neutral Do institutionals and insiders hold more shares of HCWB or IMRX? 3.0% of HCW Biologics shares are held by institutional investors. Comparatively, 67.7% of Immuneering shares are held by institutional investors. 49.9% of HCW Biologics shares are held by company insiders. Comparatively, 25.0% of Immuneering shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, HCWB or IMRX? HCW Biologics has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, Immuneering has a beta of -0.33, meaning that its stock price is 133% less volatile than the S&P 500. Is HCWB or IMRX more profitable? Immuneering has a net margin of 0.00% compared to HCW Biologics' net margin of -1,067.82%. Immuneering's return on equity of -79.19% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-1,067.82% -2,516.84% -132.95% Immuneering N/A -79.19%-69.08% Does the MarketBeat Community prefer HCWB or IMRX? Immuneering received 23 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 64.44% of users gave Immuneering an outperform vote. CompanyUnderperformOutperformHCW BiologicsOutperform Votes6100.00% Underperform VotesNo VotesImmuneeringOutperform Votes2964.44% Underperform Votes1635.56% Do analysts rate HCWB or IMRX? Immuneering has a consensus target price of $12.80, indicating a potential upside of 540.00%. Given Immuneering's stronger consensus rating and higher probable upside, analysts clearly believe Immuneering is more favorable than HCW Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Immuneering 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.38 Which has stronger earnings and valuation, HCWB or IMRX? HCW Biologics has higher revenue and earnings than Immuneering. Immuneering is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$3.50M4.86-$24.99M-$1.00-0.45Immuneering$320K194.06-$53.47M-$1.97-1.02 SummaryImmuneering beats HCW Biologics on 11 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.98M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-0.4510.5990.0517.18Price / Sales4.86195.801,117.14116.99Price / CashN/A57.1643.0437.86Price / Book1.215.094.784.78Net Income-$24.99M$151.83M$120.31M$225.60M7 Day Performance25.77%-2.13%-1.92%-1.23%1 Month Performance-36.72%-3.10%11.51%3.36%1 Year Performance-60.44%11.54%30.61%16.60% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics0.4079 of 5 stars$0.45+8.7%N/A-62.9%$16.98M$3.50M-0.4540Gap DownIMRXImmuneering3.4142 of 5 stars$1.73+5.8%$12.80+639.9%-70.1%$53.72M$320,000.00-0.8360News CoverageIMMXImmix Biopharma2.8749 of 5 stars$1.95-4.4%$7.00+259.0%-67.7%$53.64MN/A-2.479News CoverageALTSJanoneN/A$3.77-3.8%N/AN/A$53.04M$7.11M0.00170Gap UpALVRAlloVir0.7092 of 5 stars$0.45+0.4%N/A-81.8%$52.24MN/A-0.51110News CoverageSTTKShattuck Labs2.6728 of 5 stars$1.09-4.4%$8.67+695.1%-82.2%$52.04M$1.66M-0.75100IOBTIO Biotech3.2806 of 5 stars$0.79-2.8%$9.33+1,085.9%-47.9%$51.85MN/A-0.5930News CoveragePositive NewsITRMIterum Therapeutics2.0436 of 5 stars$1.87+3.9%$5.00+167.4%+6.0%$51.46MN/A-0.9410CELUCelularityN/A$2.31+4.1%N/A+36.9%$50.79M$48.20M0.00220PRLDPrelude Therapeutics2.9348 of 5 stars$0.90+12.0%$4.00+346.6%-67.3%$49.29MN/A-0.52120News CoveragePositive NewsGap UpHigh Trading VolumeVTVTvTv Therapeutics2.0038 of 5 stars$15.44+2.7%$35.00+126.7%+70.4%$49.25M$2.02M-3.329 Related Companies and Tools Related Companies Immuneering Competitors Immix Biopharma Competitors Janone Competitors AlloVir Competitors Shattuck Labs Competitors IO Biotech Competitors Iterum Therapeutics Competitors Celularity Competitors Prelude Therapeutics Competitors vTv Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCWB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCWB Stock Alerts